Gather momentum for a win-win situation! Aichuang Technology won the title of "Tencent Health Outstanding Partner of the Year"!

From September 7th to 8th, 2023, the 2023 Tencent Global Digital Ecosystem Conference was successfully held at the Shenzhen International Convention and Exhibition Center. Important academicians and scholars, business representatives, and ecological partners from the industry attended the conference and conducted in-depth and all-round exchanges and discussions around the theme of "Accelerating Intelligent Change and Renewing the Industry" to discuss the future of the big model era. New needs, new trends, and new paths for digital intelligence integration. As one of Tencent's long-term partners, Mr. Xie Zhaohui, President of Aichuang Technology, was invited to attend this conference and was awarded the "Tencent Health Outstanding Partner of the Year" and returned home with great honor!

Wu Wenda, President of Tencent Health, talked about partners in his opening speech and mentioned the results of cooperation with Aichuang Technology, "Tencent Health collaborates with Aichuang Technology to help pharmaceutical companies achieve end-to-end traceability of the entire production process, improving the traceability of drugs and devices. It is authoritative and convenient, allowing patients to obtain safer and more convenient medication guarantees. Traceability is the first step to ensure the safety of patients' medication. On this basis, Tencent Health Medicine Box, jointly built with Aichuang, can provide patients with medical Intelligent pharmaceutical services such as medication use, medication inquiry, and medication purchase provide a one-stop health management service for medication services.”

Aichuang Technology and Tencent have been hand in hand for many years. Since 2020, Aichuang Technology has carried out comprehensive cooperation in Tencent security, Tencent smart retail, Tencent medicine and other fields, especially Tencent health medicine boxes, opening up data links and efficiently reaching patients. Let pharmaceutical companies understand patients and provide them with operational services such as private domain operations and precision marketing.

Picture | Mr. Xie Zhaohui, President of Aichuang Technology (7th from the left in the picture) attended the event

On July 3, 2023, Aichuang Technology and Tencent Cloud signed a strategic cooperation agreement. Relying on Tencent Cloud's basic platform capabilities, the two parties will conduct comprehensive cooperation from multiple dimensions such as coding platform, coding management, and data analysis, targeting medicine and medical devices. The field has launched a joint product solution for full-process compliance and traceability, giving pharmaceutical and device products real, traceable and verifiable unique "code" data to meet the traceability regulatory requirements of pharmaceutical companies. After compliance, pharmaceutical companies still have problems in digital transformation. The problem of connecting upstream and downstream data in the industry and utilizing the value of the data.

Aichuangma middle platform can solve this problem very well. Aichuangma middle platform uses unique codes as the carrier, empowers business with data, unifies data standards from the production end source, and collects all touch points from the entry of pharmaceutical materials to the delivery of products. The full life cycle business data helps enterprises integrate and manage all-link data. Among them, relying on its own strong technical capabilities and solution capabilities, it uses Tencent's healthy, safe, efficient, and elastic cloud underlying technology to empower business scenarios, and uses Tencent Cloud SaaS platform product capabilities, operational capabilities, and data capabilities to improve production, supply, and services. Provide technical support in other links to avoid problems such as mistransmission and missed transmission, tap the value of data, break down data silos, help enterprises complete supply chain collaboration, tap the value of data, and truly achieve cost reduction and efficiency improvement.

Aichuoma's middle platform, coupled with Tencent Health Medicine Box and Tencent's ecological capabilities and connection capabilities, can help pharmaceutical companies build insights into patients, provide support for corporate decision-making, and promote efficient transformation; on the other hand, it can use data intelligence to Drive business growth and realize the interconnection of upstream and downstream enterprises in the industrial chain, so that all links can collaborate efficiently and the supply chain can be managed in a refined manner.

As a global traceability digital solution provider, Aicron Technology has served more than 3,000 domestic and overseas pharmaceutical company customers, including many import and export pharmaceutical companies such as AstraZeneca, Boehringer Ingelheim, Xi'an Janssen, etc., and can provide satisfactory The digital traceability system for the entire pharmaceutical industry chain required by regulations in China, the European Union, the United States and many other countries has successfully implemented the transformation of more than 20,000 production lines, completed more than 50 international projects, and has business in more than 20 countries and regions around the world. It has been widely recognized by industry partners and users.

Aichuang Technology will continue to join hands with Tencent Health to accelerate the construction of an excellent digital pharmaceutical and device service system and achieve common development and long-term win-win results with more pharmaceutical companies. In the future, Aichuang Technology and Tencent Health will combine their respective advantageous resources to continue in-depth cooperation in product solutions, business strategies, operating models, user markets, etc., give full play to the advantages of both parties, continue to innovate technology, assist the digital transformation of the pharmaceutical and device supply chain, and explore overseas markets. The new model of digital upgrading of internal and external pharmaceuticals and equipment conforms to the development of the times, continues to optimize medical services, comprehensively promotes the process of medical digitalization and intelligence, and injects new impetus into the promotion of Digital China and Healthy China strategies.

Guess you like

Origin blog.csdn.net/m0_69009806/article/details/133345956